DMSOd6): d=171.9, 143.8, 140.8, 127.5, 126.9, 125.2, 120.0, 98.5,
97.4, 66.0, 61.3, 54.4, 46.7, 29.9, 24.9, 18.8 ppm; HPLC: linear gradi-
ent of H2O/MeCN 5:95 to 0:100; tR: 10.4 min; LC–MS: m/z: calcd for
C23H25NO6: 411.4; found: 410 [MꢁH]+; HRMS: m/z: calcd for
C23H26NO6: 412.1760 [M+H]+; found: 412.1745.
MeOH (10 equiv.) to the mixture, which was stirred for 30 min at
258C. The resin was then washed with CH2Cl2 (4ꢃ5 mL) and DMF
(5ꢃ5 mL), and the Fmoc protecting group was removed by treat-
ing the resin with 20% piperidine in DMF (2ꢃ10 mL, each 10 min),
followed by washing with DMF (2ꢃ5 mL) and CH2Cl2 (2ꢃ5 mL).
The H-Leu-O-2CTC resin was divided into two portions and swelled
in CH2Cl2 (3ꢃ5 mL) and then DMF (3ꢃ5 mL). Fmoc-Ser(Thp)-OH
(3 equiv.) was added to one portion and Fmoc-Thr(Thp)-OH
(3 equiv.) was added to the other. Amino acids were coupled using
N,N’-diisopropylcarbodiimide (3 equiv.) and Oxyma Pure (3 equiv.)
in DMF with a 3 min pre-activation time for 1.5 h at 258C. The
resins were washed with CH2Cl2 (4ꢃ5 mL) and DMF (2ꢃ5 mL). The
Fmoc protecting group was removed by treating the resins with
20% piperidine in DMF (2ꢃ10 mL, each 10 min), and then Fmoc-
Ala-OH was incorporated as described above.
Synthesis of Fmoc-Thr(Thp)-OH
PTSA (14 mg, 0.073 mmol) was added to a suspension of Fmoc-
Thr-OH (500 mg, 1.46 mmol) and DHP (265 mL, 2.92 mmol) in
CH2Cl2. The mixture was allowed to react for 60 min at RT. After-
wards, the organic layer was washed with brine (3ꢃ20 mL) and
water (3ꢃ20 mL) and then dried over Na2SO4 and filtered. The sol-
vent was evaporated under reduced pressure. The crude product
was purified on a silica column using n-hexane/EtOAc (1:1). The
collected fractions were concentrated to afford a white solid
1
(453 mg, 73% yield). H NMR (400 MHz, DMSOd6): d=12.8 (s, 1H),
Cleavage Studies
7.88 (d, J=7.2 Hz, 2H), 7.77 (d, J=7.6 Hz, 2H), 7.41 (t, J=7.6 Hz,
2H), 7.32 (t, J=7.2 Hz, 2H), 7.16 (d, J=8.8 Hz, 1H), 4.77–4.62 (m,
1H), 4.33–4.18 (m, 3H), 4.17–3.98 (m, 2H), 3.85–3.66 (m, 1H), 3.45–
3.37 (m, 1H), 1.78–1.32 (m, 6H), 1.22–1.05 ppm (m, 3H); 13C NMR
(100 MHz, DMSOd6): d=171.7, 156.6, 143.9, 140.6, 127.6, 127.0,
125.3, 120.1, 99.4, 94.0, 69.5, 65.9, 60.9, 46.9, 30.1, 25.0, 20.3,
18.6 ppm; HPLC: linear gradient of H2O/MeCN 5:95 to 0:100; tR:
10.8 min; LC–MS: m/z: calcd for C24H27NO6: 425.47; found: 424
[MꢁH]+; HRMS: m/z: calcd for C24H28NO6: 426.1917 [M+H]+;
found: 426.1896.
For each cleavage study, samples of Fmoc-Ala-Xxx(Thp)-Leu-O-
2CTC resin (Xxx=Ser or Thr; 5 mg) were treated with mixtures of
TFA/H2O/TIS/CH2Cl2 (500 mL) at different percentages (Table 2) at
RT. The reaction was monitored by RP-HPLC [linear gradient of
H2O/MeCN (5:95) over 15 min] after 15, 30, and 60 min of treat-
ment. After each interval, an aliquot of 20 mL was taken, and the
solvent was then removed under a nitrogen stream and the resi-
due re-dissolved in MeCN (400 mL; Table 2).
Acknowledgements
Peptide Synthesis with Ellman (DHP) resin
Fmoc-Ser-OMe (50 mg, 0.059 mmol) in CH2Cl2 was added to Ellman
(DHP) resin (50 mg, f=1.18 mmolgꢁ1) after the latter was swelled
in CH2Cl2 for 10 min. PTSA (0.28 mg, 0.0015 mmol) in THF (1 mL)
was added to the resin. The reaction was stirred for 30 min and
the resin was then washed with CH2Cl2 (2ꢃ5 mL) and dried. The
dried resin was used to study the lability of Fmoc-Ser-OMe from
Ellman resin.
We thank Dr. Thomas Bruckdorfer from Iris Biotech (Germany) for
supporting this work and providing free samples of protected
amino acids. This work was funded in part by the following: Na-
tional Research Foundation (NRF) and the University of KwaZulu-
Natal (South Africa); the International Scientific Partnership Pro-
gram (ISPP#0061) at King Saud University (Saudi Arabia); and
MEC (CTQ2015-67870-P) and Generalitat de Catalunya (2014 SGR
137; Spain).
Lability Experiments
The protected Fmoc-Ser(Thp)-OH and Fmoc-Thr(Thp)-OH (1 mg)
were treated at RT with cleavage cocktails (200 mL), which were
CH2Cl2 solutions containing different percentages of TFA and scav-
engers (water and/or TIS; Table 1). The reaction was monitored by
RP-HPLC [linear gradient of H2O/MeCN (5:95) over 15 min] after 15,
30, and 60 min of treatment. After each interval, an aliquot of
20 mL was withdrawn, the solvent was removed under nitrogen
stream and the residue re-dissolved in MeCN (400 mL). Fmoc-
Ser(Thp)-OH, tR =10.46 min; Fmoc-Thr(Thp)-OH, tR =10.89 min.
Cleavage of Fmoc-Ser-OMe from the DHP resin was achieved using
2% TFA in the presence of TIS for 15 min.
Keywords: protecting groups · serine · solid-phase peptide
synthesis · tetrahydropyranyl group · threonine
[3] T. H. Thanka Christlet, K. Veluraja, Biophys. J. 2001, 80, 952–960.
[6] J. Kitagaki, G. Shi, S. Miyauchi, S. Murakami, Y. Yang, Anticancer Res.
[7] L. Amanda, D. Kirby, G. A. Lajoie, in Solid-Phase Synthesis: A Practical
Guide, (Eds.: S. A. Kates, F. Albericio), Marcel Dekker Inc., New York,
Basel, 2000.
[8] P. M. Fischer, K. V. Retson, M. I. Tyler, M. E. H. Howden, Int. J. Pept. Protein
Res. 1991, 38, 491–493.
Synthesis of Fmoc-Ala-Ser(Thp)-Leu-OH and Fmoc-Ala-
Thr(Thp)-Leu-OH
[9] S. Reissmann, C. Schwuchow, L. Seyfarth, L. F. P. De Castro, C. Liebmann,
[12] K. Barlos, D. Gatos, S. Koutsogianni, W. Schꢅfer, G. Stavropoulos, Y.
[13] K. Barlos, D. Gatos, S. Koutsogianni, J. Pept. Res. 1998, 51, 194–200.
Peptide syntheses were performed manually on 2-CTC resin
(50 mg, f=1.60 mmolgꢁ1). Initially, the resin was activated over-
night using thionyl chloride (10% in CH2Cl2) and then washed with
CH2Cl2 (2ꢃ5 mL). Attachment of the first amino acid was per-
formed by treating the resin with Fmoc-Leu-OH (3 equiv.) and N,N-
diisopropylethylamine (10 equiv) in CH2Cl2, and allowing it to react
for 60 min at 258C. Thereafter, the resin was capped by adding
&
ChemistryOpen 2017, 00, 0 – 0
4
ꢂ 2017 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!